The Roche eye drug Lucentis could work better than laser treatment to treat a common cause of blindness amongst people with diabetes, according to the US National Eye Institute. Using the drug alongside laser treatment was found to be particularly effective, according to the Diabetic Retinopathy Clinical Research Network.
Lucentis, which is known generically as Ranibizumab, is an engineered immune system particle that targets the blood vessels in the eye. The drug is already approved to treat macular degeneration, but the potential could exist to treat millions of people suffering from diabetic eye complications .
The research team found that Lucentis was extremely effective, according to a report in the journal Ophthalmology. They reportedly commented: "After one year, nearly 50 percent of eyes treated with ranibizumab and prompt or deferred laser treatment showed a substantial visual improvement."
Roche eye drug could treat diabetes retinopathy
Wed, 28 Apr 2010
Recommended links
Diabetes forumDiabetes donate
Diabetes myLifestyle
Diabetes food and recipes
The Diet Plate for People with Diabetes
Diabetes pensions and annuities
Diabetes.co.uk ID alert wristband
Victoza may be a more effective diabetes drug than Januvia
Lung cancer prevention from diabetes drug
Diabetes drug study positive according to Sanofi
Diabetes drug distribution suspended in Saudi Arabia
Diabetes management system approved by Food and Drug Administration
Food and Drug Administration call for more information on Amylin diabetes drug
Supporters of diabetes drug had financial ties to pharmaceutical company
Diabetes injection Byetta LAR faces Food and Drug Administration decision
GlaxoSmithKline defends diabetes drug Avandia
Patient concern over diabetes drug Avandia
Food and Drug Administration say diabetes patients should not stop taking Avandia
Popular Cholesterol drugs increase diabetes risk
Smell of fish may put patients off diabetes drug
24 hour Diabetes drug Victoza approved for National Health Service use
Diabetes drug could cut body mass index
Weight loss drug alli could reduce dangerous diabetes fat
Type 2 diabetes drug gets Food and Drug Administration approval
Lexicon diabetes drug hits mid-stage trial
Diabetes drug clinical trials underway
Death risk increased 60 per cent by diabetes drug
Roche diabetes drug hits targets
